Bio-Rad Reports Second-Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. UNH
7. TMUS
8. SPY
9. CVS
10. SBUX

Go back to Bio-Rad Reports Second-Quarter 2024 Financial Results

Bio-Rad Labs (BIO) Tops Q2 EPS by $1.10, Misses on Revenue; Offers Q3 Guidance

August 1, 2024 4:27 PM EDT

Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.11, $1.10 better than the analyst estimate of $2.01. Revenue for the quarter came in at $638.5 million versus the consensus estimate of $645.79 million.

GUIDANCE:

Bio-Rad Labs sees Q3 2024 revenue of $638.5-681.1 million, versus the consensus of... More